Tiny study aims to sharpen MRI scans by tweaking dye injection

NCT ID NCT07346131

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests how the speed and volume of a contrast agent injection affect MRI image quality. Ten healthy volunteers will each have five abdominal MRI scans with different injection methods. Three radiologists will then rate the images to find the best approach, which could help improve future scans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

gadopiclenol (a gadolinium-based contrast agent)

What this could lead to

If successful, this could help doctors choose the best injection method for clearer MRI images, potentially improving diagnosis.

What could go wrong

This is a very small, early-phase study in healthy volunteers, not patients. Results may not apply to real-world medical imaging or different populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRAST AGENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HFR Hôpital fribourgeois

    Fribourg, Canton of Fribourg, 1700, Switzerland